Terms ending in 2041
Every in-force patent on Danisco US Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,606,599 | Over-Expression of GDS1 in Yeast for Increased Ethanol and Decreased Acetate Production In force · Medium confidence | Danisco US Inc. | In force | Medium confidence | |
| US 11,918,011 | High-Payload, Non-Porous, Enzyme-Containing Coated Granules and Use of Same In force · High confidence | Danisco US Inc. | In force | High confidence | |
| US 11,976,266 | Filamentous Fungal Strains Comprising Reduced Viscosity Phenotypes In force · High confidence | Danisco US Inc. | In force | High confidence | |
| US 11,879,127 | Methods and Compositions for Efficient Genetic Modifications of Bacillus Licheniformis Strains In force · High confidence | Danisco US Inc. | In force | High confidence | |
| US 12,084,728 | Increasing Severity Acid Hydrolysis Assays for Determining the Amount of Glucose Derivable from Cellulose in Feedstocks In force · High confidence | Archer Daniels Midland Company | In force | High confidence | |
| US 12,232,512 | Methods for Improving the Amino Acid Content of Animal Feed Products In force · High confidence | Danisco US Inc. | In force | High confidence | |
| US 12,268,219 | Lactic Acid Bacterium with a Reduction of Sensitivity to Cos-Type Bacteriophages In force · High confidence | Dupont Nutrition Biosciences APS | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Danisco US Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.